SCHEDULES

SCHEDULE 8Material to accompany an application for a UK marketing authorisation

PART 1General requirements

13

The risk management plan, together with a summary, that—

a

describes the risk management system which the applicant will introduce for the medicinal product concerned; and

b

shall be proportionate to the identified risks and the potential risks of the medicinal product, and the need for post-authorisation safety data.